Feng Xue

Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system

Cuicui Lyu, Jun Shen, Rui Wang et al. · Stem Cell Research & Therapy · 2018 · 104 citations · Full text

Life Sciences, Biotechnology, Genetics +17

Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial

Feng Xue, Huiyuan Li, Xia Wu et al. · The Lancet Haematology · 2022 · 79 citations

Life Sciences, Hematology, Pharmacotherapy +12

Multi-omics analysis of human mesenchymal stem cells shows cell aging that alters immunomodulatory activity through the downregulation of PD-L1

Yuchen Gao, Ying Chi, Yunfei Chen et al. · Nature Communications · 2023 · 79 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Nongenotoxic antibody-drug conjugate conditioning enables safe and effective platelet gene therapy of hemophilia A mice

Chunyan Gao, Jocelyn A. Schroeder, Feng Xue et al. · Blood Advances · 2019 · 51 citations · Full text

Pharmacy, Hematology, Pharmaceutical Biotechnology +10

Outcome of CARE: a 6‐year national registry of acquired haemophilia A in China

Boyang Sun, Feng Xue, Ying Feng et al. · British Journal of Haematology · 2019 · 47 citations · Full text

Medicine, Hematology, Immunology +17